Skip to main content
. 2018 Nov 19;219(8):1318–1328. doi: 10.1093/infdis/jiy654

Figure 2.

Figure 2.

Immunofluorescence assay for total anti– Kaposi sarcoma (KS)–associated herpesvirus (KSHV) antibody from plasma of KS patients and noncancer control subjects (reciprocal endpoint plasma dilution). A, Anti-KSHV antibody titer in plasma of KS patients and noncancer control subjects. B, Anti-KSHV antibody titer in human immunodeficiency virus type 1 plasma viremic and aviremic epidemic KS patients. Abbreviations: HIV-1, human immunodeficiency virus type 1; KSHV, Kaposi sarcoma–associated herpesvirus.